CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
The human immunodeficiency virus type 1 (HIV-1) genes vpu, env, and nef have all been implicated in modulating the levels of cell surface CD4 on infected cells. To quantitatively assess the relative contribution of each gene product to the regulation of CD4 during HIV infection of Jurkat T cells and peripheral blood mononuclear cells, we have developed an infectious HIV reporter system which expresses different combinations of these genes. To distinguish infected cells in the early or late stages of infection from uninfected cells, these viruses were designed to express human placental alkaline phosphatase with the kinetics of either early or late viral genes. Flow cytometry to detect placental alkaline phosphatase and CD4 in infected cells showed that vpu, env, and nef are independently capable of down-modulation of CD4. As predicted by their respective expression patterns, nef down-modulated CD4 rapidly during the early phase of virus infection whereas vpu and env functioned late in the infection. In both Jurkat cells and peripheral blood mononuclear cells, a combination of the three genes was more efficient than any one or two genes, demonstrating that all three genes are required to achieve maximal CD4 down-modulation. In primary cells, down-modulation of CD4 was less efficient than in Jurkat cells and there was a stronger dependence on nef function for reducing cell surface CD4. HIV therefore has three genes that are able to independently down-modulate CD4; together, they can eliminate the bulk of cell surface CD4.
Chen
B K
BK
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.
Gandhi
R T
RT
Baltimore
D
D
D000469:Alkaline Phosphatase / Q000096:biosynthesis; D015703:Antigens, CD / Q000096:biosynthesis*; D001483:Base Sequence; D015153:Blotting, Western; D015704:CD4 Antigens / Q000096:biosynthesis*; D002460:Cell Line; D002999:Clone Cells; D004256:DNA Polymerase I / Q000378:metabolism; D017931:DNA Primers; D004279:DNA, Viral / Q000096:biosynthesis; D005260:Female; D005434:Flow Cytometry; D015967:Gene Expression Regulation, Viral; D015752:Genes, env; D015754:Genes, nef; D016338:Genes, vpu; D005838:Genotype; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008156:Luciferases / Q000096:biosynthesis; D008214:Lymphocytes / Q000276:immunology* / Q000821:virology; D008969:Molecular Sequence Data; D010920:Placenta / Q000201:enzymology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011533:Proviruses / Q000235:genetics / Q000276:immunology; D012326:RNA Splicing; D012333:RNA, Messenger / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012270:Ribosomes / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology* / Q000821:virology*; D014162:Transfection; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D015704:CD4 Antigens; D017931:DNA Primers; D004279:DNA, Viral; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D008156:Luciferases; D004256:DNA Polymerase I; D000469:Alkaline Phosphatase